Aptorum Group Limited - Class A Ordinary Shares (APM): Price and Financial Metrics

Aptorum Group Limited - Class A Ordinary Shares (APM): $5.66

0.09 (-1.57%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

APM Price/Volume Stats

Current price $5.66 52-week high $17.49
Prev. close $5.75 52-week low $1.35
Day low $5.54 Volume 19,400
Day high $6.22 Avg. volume 1,998,941
50-day MA $5.77 Dividend yield N/A
200-day MA $2.95 Market Cap 20.22M

APM Stock Price Chart Interactive Chart >


Aptorum Group Limited - Class A Ordinary Shares (APM) Company Bio


Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.


APM Latest News Stream


Event/Time News Detail
Loading, please wait...

APM Latest Social Stream


Loading social stream, please wait...

View Full APM Social Stream

Latest APM News From Around the Web

Below are the latest news stories about APTORUM GROUP LTD that investors may wish to consider to help them evaluate APM as an investment opportunity.

APM Stock: Is It Worth Investing In APM?

Aptorum Group is a clinical-stage biopharmaceutical company based in the UK, dedicated to the exploration, development, and commercialization of therapeutic assets for the treatment of diseases with unmet medical needs. 

TalkMarkets.com | December 29, 2023

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023

NEW YORK & LONDON, December 22, 2023--Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2023.

Yahoo | December 22, 2023

Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders

NEW YORK & LONDON, December 21, 2023--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its 2023 annual general meeting of shareholders, which was held on December 20, 2023, in London.

Yahoo | December 21, 2023

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023

NEW YORK & LONDON, November 16, 2023--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that it will hold its 2023 annual general meeting of shareholders at its London office located at 17 Hanover Square, Mayfair London, England W1S 1BN at 1:00 p.m. London Time on December 20, 2023 (8:00 a.m. Eastern Standard Time on Decem

Yahoo | November 16, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning!

William White on InvestorPlace | August 28, 2023

Read More 'APM' Stories Here

APM Price Returns

1-mo -26.97%
3-mo N/A
6-mo 209.29%
1-year 92.52%
3-year -77.45%
5-year -96.09%
YTD 131.15%
2023 -55.49%
2022 -63.33%
2021 -39.27%
2020 -84.42%
2019 4.41%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!